TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31202508

Group type: EXPERIMENTAL
Intervention: Ibuprofen acid orodispersible tablets (Test product)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Ibuprofen acid oral tablets (Reference product)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Ibuprofen S(+) and R(−) enantiomers
Number of subjects: 36
Study: 29395273

Group type: EXPERIMENTAL
Intervention: Cannabidiol 20 mg/kg oral daily for 14 weeks
Number of subjects: 171

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Cannabidiol
Number of subjects: 171
Study: 27028371

Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia
Number of subjects: 140

Group type: COMPARATOR
Intervention: Epidural anesthesia
Number of subjects: 140
Study: 25148049

Group type: EXPERIMENTAL
Intervention: Azithromycin 250 mg daily for 12 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Azithromycin treatment
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Chest CT scans (sub-group of participants)
Number of subjects: 30
Study: 22178268

Group type: EXPERIMENTAL
Intervention: Terlipressin (short course, 24 hours)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Terlipressin (usual course, 72 hours)
Number of subjects: 130
Study: 20101593

Group type: EXPERIMENTAL
Intervention: Preoperative oral carbohydrate (OCH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fasting
Number of subjects: 0
Study: 18807578

Group type: EXPERIMENTAL
Intervention: Test formulation of omeprazole (20 mg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Reference formulation of omeprazole (20 mg)
Number of subjects: 50
Study: 17283347

Group type: EXPERIMENTAL
Intervention: 30‐minute session of motivational counseling during hospitalization (n = 172)
Number of subjects: 341

Group type: COMPARATOR
Intervention: Usual care (n = 169)
Number of subjects: 341
Study: 12823078

Group type: EXPERIMENTAL
Intervention: Morning light therapy (30 minutes of 400 lux green light treatment)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Citalopram (40 mg) with morning light therapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Citalopram (40 mg) with placebo (deactivated negative ion generator)
Number of subjects: 30
Study: 10702431

Group type: EXPERIMENTAL
Intervention: Transgenic recombinant antithrombin
Number of subjects: 0
Study: 9100603

Group type: EXPERIMENTAL
Intervention: Estradiol (E2; 48 micrograms/day)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: 5 alpha-dihydrotestosterone (DHT; 7.0 mg/day)
Number of subjects: 5

Group type: COMPARATOR
Intervention: 5% dextrose in water (control)
Number of subjects: 5
Study: 8448069

Group type: EXPERIMENTAL
Intervention: alpha MeHA, 10 mg (as a chloride salt)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 6
Study: 3768929

Group type: EXPERIMENTAL
Intervention: 2.5 mg/day of metolazone
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: 25 mg of chlorthalidone
Number of subjects: 187

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Metolazone
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Chlorthalidone
Number of subjects: 187
Study: 29970355

Group type: EXPERIMENTAL
Intervention: Web-based partner notification (n=95)
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Web-based partner notification with partner referral cards (n=84)
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Partner referral cards (n=97)
Number of subjects: 370

Group type: COMPARATOR
Intervention: Simple partner notification counseling (control; n=94)
Number of subjects: 370
Study: 26524001

Group type: EXPERIMENTAL
Intervention: Utility-value intervention where students wrote about the personal relevance of course material
Number of subjects: 1040

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 1040

Group type: EXPERIMENTAL
Intervention: Utility-value intervention
Number of subjects: 1040
Study: 24706489

Group type: EXPERIMENTAL
Intervention: Romiplostim
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study: 22228217

Group type: EXPERIMENTAL
Intervention: Screen-based computer simulation (n = 41)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Skill laboratories (n = 41)
Number of subjects: 82
Study: 21245500

Group type: COMPARATOR
Intervention: Treadmill running at 3.35 m/s ± 5%
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Overground running at 3.35 m/s ± 5%
Number of subjects: 20
Study: 18565100

Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 52

Group type: COMPARATOR
Intervention: Tacrolimus
Number of subjects: 52
Study: 16428156

Group type: COMPARATOR
Intervention: Vehicle application of 70% alcohol
Number of subjects: 114

Group type: COMPARATOR
Intervention: 10% phenol in 70% alcohol
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: 12% salicylic acid gel
Number of subjects: 114
Study: 12588471

Group type: EXPERIMENTAL
Intervention: Combined cold and citrus (CD + CT)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Room temperature (RT)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Combined cold and citrus (CD + CT) in healthy young subjects (<60 years)
Number of subjects: 87
Study: 10226719

Group type: EXPERIMENTAL
Intervention: Fluoride varnish (Duraphat) applied 3-4 times a year for 4 years
Number of subjects: 269

Group type: COMPARATOR
Intervention: No professional fluoride application (Control group)
Number of subjects: 269
Study: 9162365

Group type: EXPERIMENTAL
Intervention: Percutaneous aspiration and continuous drainage over 24 hours (group 2)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Percutaneous aspiration alone (group 1)
Number of subjects: 32
Study: 1907241

Group type: EXPERIMENTAL
Intervention: Intracoronary streptokinase (thrombolytic therapy)
Number of subjects: 533

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 533
Study: 6809158

Group type: EXPERIMENTAL
Intervention: Heat-stable measles vaccine; stored unreconstituted at 37 degrees C for 14 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heat-stable measles vaccine; reconstituted and stored at 25 degrees C for 48 hours and at 37 degrees C for at least four hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional measles vaccines
Number of subjects: 0
Study: 30570584

Group type: EXPERIMENTAL
Intervention: Calcium phosphate double‐coated anorganic bovine bone (InduCera)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Anorganic bovine bone (Bio‐Oss)
Number of subjects: 25
Study: 28683994

Group type: EXPERIMENTAL
Intervention: Intravenous methylprednisolone, 250 mg at anesthetic induction and 250 mg at initiation of CPB (n=44)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo (n=37)
Number of subjects: 81
Study: 25712416

Group type: EXPERIMENTAL
Intervention: High-dose atorvastatin (80 mg the day before PCI and 40 mg 2-4 h before PCI)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Low-dose statins
Number of subjects: 23
Study: 23811624

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided caudal block with 8 ml of 0.3% ropivacaine and 100 µg of fentanyl
Number of subjects: 48

Group type: COMPARATOR
Intervention: Non-block (no caudal block)
Number of subjects: 48
Study: 22066975

Group type: EXPERIMENTAL
Intervention: Exercise group (n = 40) performing daily exercise with weekly load increase for 3 months
Number of subjects: 81

Group type: COMPARATOR
Intervention: Reference group (n = 41) wait-listed
Number of subjects: 81
Study: 18271691

Group type: EXPERIMENTAL
Intervention: Low-calorie diet (LCD) with yogurt enriched by low doses of n-3 PUFA (n-3 LCD)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low-calorie diet (LCD)
Number of subjects: 40
Study: 16942967

Group type: EXPERIMENTAL
Intervention: Primary Care Triple P-Positive Parenting Program intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 0
Study: 12738506

Group type: EXPERIMENTAL
Intervention: GnRH agonist
Number of subjects: 16

Group type: COMPARATOR
Intervention: hCG
Number of subjects: 16
Study: 10853928

Group type: EXPERIMENTAL
Intervention: Brimonidine 0.2%
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Dorzolamide 2%
Number of subjects: 28
Study: 9351414

Group type: EXPERIMENTAL
Intervention: Vaginal prostaglandin (PG) (PGE1, gemeprost 1 mg) preoperatively + GA
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Vaginal prostaglandin (PG) (PGE1, gemeprost 1 mg) preoperatively + GA + PCB
Number of subjects: 200

Group type: COMPARATOR
Intervention: GA without PG treatment
Number of subjects: 200

Group type: COMPARATOR
Intervention: GA + PCB without preoperative PG
Number of subjects: 200

Group type: COMPARATOR
Intervention: GA + PCB
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Vaginal prostaglandin (PG) (PGE1, gemeprost 1 mg) preoperatively
Number of subjects: 200
Study: 8465022

Group type: EXPERIMENTAL
Intervention: Ro 03-8799 (pimonidazole)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Control arm (radiotherapy)
Number of subjects: 183
Study: 3517799

Group type: EXPERIMENTAL
Intervention: Increased carrying
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 99
Study: 30518237

Group type: EXPERIMENTAL
Intervention: Computer-based language training
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Paper/pencil language training
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Oral language training
Number of subjects: 71

Group type: COMPARATOR
Intervention: Unstructured sessions (control)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Waiting list (control)
Number of subjects: 71
Study: 29453708

Group type: EXPERIMENTAL
Intervention: Peer mediated PEERS curriculum
Number of subjects: 34

Group type: COMPARATOR
Intervention: Traditional PEERS curriculum
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Typically developing peer mentors
Number of subjects: 34
Study: 28524097

Group type: EXPERIMENTAL
Intervention: Higher intakes of vegetables (specifically cruciferous and allium vegetables)
Number of subjects: 1468

Group type: COMPARATOR
Intervention: Fruits
Number of subjects: 1468
Study: 25767372

Group type: EXPERIMENTAL
Intervention: rosuvastatin (20 mg/day) + valsartan (160 mg/day)
Number of subjects: 30
Study: 23859304

Group type: EXPERIMENTAL
Intervention: Triclosan impregnated 2‐0 polydioxanone loop suture
Number of subjects: 856

Group type: COMPARATOR
Intervention: 2‐0 polydioxanone loop suture
Number of subjects: 856
Study: 21946400

Group type: EXPERIMENTAL
Intervention: Ultrasound
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Laser therapy
Number of subjects: 63

Group type: COMPARATOR
Intervention: Sham laser therapy
Number of subjects: 63
Study: 18441375

Group type: EXPERIMENTAL
Intervention: Nortriptyline plus nicotine replacement therapy
Number of subjects: 901

Group type: COMPARATOR
Intervention: Placebo plus nicotine replacement therapy
Number of subjects: 901

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 901
Study: 17160302

Group type: EXPERIMENTAL
Intervention: Manual Vacuum Aspiration (MVA)
Number of subjects: 50

Group type: COMPARATOR
Intervention: D&C (Dilation and Curettage)
Number of subjects: 50
Study: 14527864

Group type: EXPERIMENTAL
Intervention: Messages matched to an individual's NFC
Number of subjects: 602

Group type: COMPARATOR
Intervention: Messages mismatched to an individual's NFC
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Tailored pamphlet
Number of subjects: 602
Study: 11431228

Group type: EXPERIMENTAL
Intervention: Guanfacine
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 9731682

Group type: EXPERIMENTAL
Intervention: Forced air warming system (n = 32)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Warmed blanket group (n = 32)
Number of subjects: 64
Study: 7868440

Group type: EXPERIMENTAL
Intervention: Pressure-support ventilation (PSV) levels from 0 to 15 cmH2O
Number of subjects: 7
Study: 2923005

Group type: EXPERIMENTAL
Intervention: High-potency marijuana cigarette
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo marijuana cigarette
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (resting conditions)
Number of subjects: 0
Study: 31779535

Group type: EXPERIMENTAL
Intervention: Green Dot intervention
Number of subjects: 10
Study: 29211671

Group type: EXPERIMENTAL
Intervention: Pharmacomechanical thrombolysis
Number of subjects: 692

Group type: COMPARATOR
Intervention: Control (anticoagulation alone)
Number of subjects: 692
Study: 25749306

Group type: EXPERIMENTAL
Intervention: Nortriptyline-Morphine Combination
Number of subjects: 52

Group type: COMPARATOR
Intervention: Nortriptyline
Number of subjects: 52

Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 52
Study: 23701004

Group type: EXPERIMENTAL
Intervention: Web-based hearing protection training program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 21085983

Group type: EXPERIMENTAL
Intervention: Walk-run transition speed (WRTS) determination protocol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cardio-respiratory responses at WRTS
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Perceived exertion (PE)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Electromyographic (EMG) variables
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Linear regression between EMG series and VO(2) data
Number of subjects: 12
Study: 19929666

Group type: EXPERIMENTAL
Intervention: Subcutaneous infiltration of local anaesthetic
Number of subjects: 32

Group type: COMPARATOR
Intervention: Regional nerve block
Number of subjects: 32
Study: 17180619

Group type: EXPERIMENTAL
Intervention: L: ‐tryptophan (Trp)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (Plac)
Number of subjects: 8
Study: 14982243

Group type: EXPERIMENTAL
Intervention: Methylphenidate (0.5 mg/kg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 11172150

Group type: EXPERIMENTAL
Intervention: 9 Gy radiation
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: 12 Gy radiation
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: 15 Gy radiation
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: 18 Gy radiation
Number of subjects: 181

Group type: COMPARATOR
Intervention: Balloon angioplasty alone
Number of subjects: 181
Study: 9644320

Group type: EXPERIMENTAL
Intervention: TAT-59 (miproxifene phosphate) 20 mg orally for over 12 weeks
Number of subjects: 195

Group type: COMPARATOR
Intervention: Tamoxifen citrate (TAM) 20 mg orally for over 12 weeks
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: TAT-59
Number of subjects: 195

Group type: COMPARATOR
Intervention: Tamoxifen citrate (TAM)
Number of subjects: 195
Study: 8159440

Group type: EXPERIMENTAL
Intervention: Hyperglycemia (blood glucose elevated to 12 mmol/l for 0.5 h and kept at that level for 2.5 h)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Euglycemia (blood glucose kept at 6 mmol/l for 3 h)
Number of subjects: 10
Study: 30832575

Group type: EXPERIMENTAL
Intervention: Further Enabling Care at Home (FECH) program
Number of subjects: 141

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 141
Study: 30256811

Group type: EXPERIMENTAL
Intervention: High dose vitamin D (10,000 IU/day)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: High dose vitamin D (10,000 IU/day) in younger participants (ages 52-66)
Number of subjects: 51
Study: 27178513

Group type: EXPERIMENTAL
Intervention: Intratympanic dexamethasone (ITD) plus high dosage of betahistine (HDBH)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Intratympanic dexamethasone (ITD) plus placebo
Number of subjects: 66
Study: 24231759

Group type: EXPERIMENTAL
Intervention: Pediatric Advanced Life Support reconstructed
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard Pediatric Advanced Life Support
Number of subjects: 40
Study: 22430270

Group type: EXPERIMENTAL
Intervention: TET2 mutations (TET2(mut))
Number of subjects: 783

Group type: EXPERIMENTAL
Intervention: Combination of TET2(mut) and/or IDH(mut)
Number of subjects: 783
Study: 20332125

Group type: EXPERIMENTAL
Intervention: Omnitrope 3.3 mg/ml solution
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Omnitrope 6.7 mg/ml solution
Number of subjects: 36

Group type: COMPARATOR
Intervention: Omnitrope 5 mg/ml powder
Number of subjects: 36

Group type: COMPARATOR
Intervention: Genotropin 5 mg/ml powder
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 36
Study: 18990049

Group type: EXPERIMENTAL
Intervention: Real acupuncture (deep needling at classic acupuncture points and tender points; n = 7)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham acupuncture (superficial needling at nonacupuncture points; n = 8)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (no needling; n = 7)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control
Number of subjects: 22
Study: 15659145

Group type: EXPERIMENTAL
Intervention: Everolimus 1.5 mg/d
Number of subjects: 634

Group type: EXPERIMENTAL
Intervention: Everolimus 3.0 mg/d
Number of subjects: 634

Group type: COMPARATOR
Intervention: Azathioprine
Number of subjects: 634
Study: 12617381

Group type: EXPERIMENTAL
Intervention: Additional upper limb physiotherapy (115 minutes, twice per day)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Wrist extension measurement (twice daily with an electrogoniometer for 3-4 weeks)
Number of subjects: 4
Study: 10669898

Group type: EXPERIMENTAL
Intervention: Diclofenac suppository (100 mg)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Diclofenac injection (75 mg)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both formulations of diclofenac (suppository and injection)
Number of subjects: 44
Study: 8933850

Group type: EXPERIMENTAL
Intervention: Desflurane (group I, n = 15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Isoflurane (group II, n = 15)
Number of subjects: 30
Study: 1913092

Group type: EXPERIMENTAL
Intervention: Duplex scanning
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: IADSA
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Duplex scanning and IADSA
Number of subjects: 60

Group type: COMPARATOR
Intervention: IAPM
Number of subjects: 60
Study: 7035298

Group type: EXPERIMENTAL
Intervention: Metronidazole
Number of subjects: 18

Group type: COMPARATOR
Intervention: Neomycin
Number of subjects: 18
Study: 30177460

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg BID as monotherapy
Number of subjects: 3881

Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg BID as monotherapy
Number of subjects: 3881

Group type: COMPARATOR
Intervention: Tofacitinib 5 mg BID in combination therapy with csDMARDs
Number of subjects: 3881

Group type: COMPARATOR
Intervention: Tofacitinib 10 mg BID in combination therapy with csDMARDs
Number of subjects: 3881
Study: 26922827

Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT) for 4 weeks
Number of subjects: 19

Group type: COMPARATOR
Intervention: Waiting period without intervention (Control) for 4 weeks
Number of subjects: 19
Study: 24681658

Group type: EXPERIMENTAL
Intervention: Active skin-surface warming
Number of subjects: 40

Group type: COMPARATOR
Intervention: Passive insulation
Number of subjects: 40
Study: 23243977

Group type: EXPERIMENTAL
Intervention: Rotation/Oscillation power toothbrush (Oral‐B Triumph with SmartGuide)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Sonic power toothbrush (Sonicare DiamondClean)
Number of subjects: 130
Study: 19595327

Group type: EXPERIMENTAL
Intervention: Dopexamine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Dopamine
Number of subjects: 30
Study: 18520610

Group type: EXPERIMENTAL
Intervention: VerifyNow P2Y12 assay
Number of subjects: 68

Group type: COMPARATOR
Intervention: Thrombin receptor activating peptide-induced platelet aggregation
Number of subjects: 68
Study: 16135980

Group type: EXPERIMENTAL
Intervention: Prone position on a modified Relton‐Hall spine support
Number of subjects: 30

Group type: COMPARATOR
Intervention: Knee-chest position on an Andrews‐type table
Number of subjects: 30
Study: 11915672

Group type: EXPERIMENTAL
Intervention: Model intervention (involvement of parents and courses for teachers)
Number of subjects: 4215

Group type: COMPARATOR
Intervention: Control (A)
Number of subjects: 4215

Group type: EXPERIMENTAL
Intervention: Intervention (B)
Number of subjects: 4215

Group type: EXPERIMENTAL
Intervention: Intervention (C)
Number of subjects: 4215

Group type: EXPERIMENTAL
Intervention: Intervention (D)
Number of subjects: 4215
Study: 10413264

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 219

Group type: COMPARATOR
Intervention: Diet
Number of subjects: 219

Group type: COMPARATOR
Intervention: Diet and Exercise
Number of subjects: 219

Group type: COMPARATOR
Intervention: No Active Intervention
Number of subjects: 219
Study: 7549057

Group type: EXPERIMENTAL
Intervention: FK506
Number of subjects: 121

Group type: COMPARATOR
Intervention: CsA
Number of subjects: 121
Study: 2197345

Group type: EXPERIMENTAL
Intervention: Strain 57-1 (10^5-10^10 CFU)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Strain C1845 (10^5-10^10 CFU)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Both strains (10^5-10^10 CFU)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Both strains (highest doses)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Both strains
Number of subjects: 43
Study: 6992822

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 29299814

Group type: EXPERIMENTAL
Intervention: Community arm (expert lectures in library)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Clinic arm (one-on-one meetings with community health worker)
Number of subjects: 111
Study: 27842530

Group type: EXPERIMENTAL
Intervention: Interactive multimedia eBook (IME)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Traditional PowerPoint (TPP)
Number of subjects: 51
Study: 24015984

Group type: EXPERIMENTAL
Intervention: Internet-based smartphone application for self-control training (modified Stroop-task) delivered daily over 4 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: No training (control group)
Number of subjects: 0
Study: 23097968

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.375% with lidocaine 1.0%
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.75% with lidocaine 1.0%
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25% with lidocaine 1.0%
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5% with lidocaine 1.0%
Number of subjects: 100